[Postcovid sino-orbital mucormycosis: a case report].
V N KolesnikovA A KhanamirovN V BoykoM A LapinS D StagnievPublished in: Vestnik otorinolaringologii (2022)
We describe a case of postcovid sino-orbital mucormycosis in a 74-year-old patient with diabetes mellitus. Orbital symptoms appeared after discharge from the covid hospital, in the third week of the disease and were represrnted by ptosis, proptosis, ophthalmoplegia, blindness and pain in the right eye, numbness of the right half of the face, edema of the periorbital region and cheek. The diagnosis of mucormycosis was confirmed by fluorescence microscopy of the discharge from the middle nasal meatus. SCT of the paranasal sinuses revealed pansinusitis with predominant destructive changes in the right maxillary, ethmoid and sphenoid sinuses. The patient underwent emergency endoscopic debridment, orbital decompression, orbitotomy; treatment with amphotericin B intravenously was started. 10 days after due to the deterioration of the patient's condition, more aggressive debridment of paranasal sinuses was performed: right maxillary sinus anterior, posterior and medial walls resection, medial orbital wall resection, necrectomy of the nasal cavity, paranasal sinuses, orbit, pterygopalatine fossa. Antifungal treatment was continued in the postoperative period. The patient was discharged on the 22nd day of stay in the ENT hospital.
Keyphrases
- case report
- healthcare
- single molecule
- emergency department
- coronavirus disease
- public health
- randomized controlled trial
- chronic pain
- type diabetes
- pain management
- physical activity
- minimally invasive
- high throughput
- neuropathic pain
- spinal cord injury
- spinal cord
- metabolic syndrome
- mass spectrometry
- candida albicans
- ultrasound guided
- sleep quality
- optical coherence tomography
- acute care
- combination therapy
- cone beam computed tomography
- skeletal muscle
- high speed
- label free